These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3673381)

  • 41. Cu, Zn- and Mn-superoxide dismutase levels in brains of patients with schizophrenic psychosis.
    Michel TM; Thome J; Martin D; Nara K; Zwerina S; Tatschner T; Weijers HG; Koutsilieri E
    J Neural Transm (Vienna); 2004 Sep; 111(9):1191-201. PubMed ID: 15338334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Physiologically active brain proteins as possible markers of mental diseases].
    Burbaeva GSh
    Vestn Ross Akad Med Nauk; 1992; (7):51-4. PubMed ID: 1281711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Creatine phosphokinase in Rana pipiens: expression in embryos, early larvae and adult tissues.
    Klemann SW; Pfohl RJ
    Comp Biochem Physiol B; 1982; 73(4):907-14. PubMed ID: 6983949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The complex neurochemical assessment of brain proteins in mentally healthy subjects and schizophrenic patients].
    Burbaeva GSh; Boksha IS; Sudakov SA; Miasoedov SN; Savushkina OK; Tereshkina EB; Starodubtseva LI; Turishcheva MS; Vorob'eva EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(2):44-50. PubMed ID: 18427502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and risk factors of benign creatine phosphokinase elevations in chronic psychiatric patients.
    Terao T; Matsuda S; Kojima H; Okuno K; Hori H; Kaku A; Ueda N; Etoh A
    Neuropsychobiology; 1999 May; 39(4):173-80. PubMed ID: 10343181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experimental contribution to the evaluation of the importance of changes in serum creatine kinase in the diagnosis of hypoxic brain damage].
    Trojanová M; Mourek J
    Sb Lek; 1987; 89(11-12):340-7. PubMed ID: 3445118
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparative study of serum creatine phosphokinase (CPK) activity in rabbits, pigs and humans after intramuscular injection of local damaging drugs.
    Steiness E; Rasmussen F; Svendsen O; Nielsen P
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):357-64. PubMed ID: 581031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum creatine phosphokinase (CPK) activity in monozygotic twins discordant for schizophrenia: heritability of serum CPK activity.
    Meltzer HY; Belmaker R; Wyatt RJ; Pollin W; Cohen S
    Compr Psychiatry; 1976; 17(3):469-75. PubMed ID: 6211
    [No Abstract]   [Full Text] [Related]  

  • 49. [Action of blood plasma of schizophrenics treated with psychotropic agents on the human embryonal brain tissue in tissue culture].
    Naneischwili BR; Surabaschwili SA; Eliawa LA
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():93-5. PubMed ID: 829643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Black-white differences in serum creatine phosphokinase (CPK) activity.
    Meltzer HY; Holy PA
    Clin Chim Acta; 1974 Jul; 54(2):215-24. PubMed ID: 4850791
    [No Abstract]   [Full Text] [Related]  

  • 51. Serum creatine phosphokinase levels in patients meeting the St. Louis research diagnostic criteria for schizophrenia.
    Schubert DS; Brocco K; Miller FT; Patterson M
    Am J Psychiatry; 1982 Apr; 139(4):491-3. PubMed ID: 7065296
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid creatine phosphokinase in the normal dog.
    Wilson JW; Wiltrout SK
    Am J Vet Res; 1976 Sep; 37(9):1099-100. PubMed ID: 962212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Latent activity of liposomal creatine phosphokinase].
    Davidenkova EF; Rozenberg OA; Shvarts EI
    Biull Eksp Biol Med; 1977 Jun; 83(6):673-5. PubMed ID: 884294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rat brain MM and MB isoenzymes of creatine kinase.
    Ramírez O; Licea G
    Exp Neurol; 1982 Jul; 77(1):225-9. PubMed ID: 7084393
    [No Abstract]   [Full Text] [Related]  

  • 55. S-adenosylmethionine-dependent N-methyltransferase activity in autopsied brain parts of chronic schizophrenics and controls.
    Erdelyi E; Elliott GR; Wyatt RJ; Barchas JD
    Am J Psychiatry; 1978 Jun; 135(6):725-8. PubMed ID: 655283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychomotor activity and serum creatine phosphokinase activity.
    Foster FG; Kupfer DJ
    Arch Gen Psychiatry; 1973 Dec; 29(6):752-8. PubMed ID: 4751815
    [No Abstract]   [Full Text] [Related]  

  • 57. Association of creatine phosphokinase with the cytoskeleton of cultured mammalian cells.
    Eckert BS; Koons SJ; Schantz AW; Zobel CR
    J Cell Biol; 1980 Jul; 86(1):1-5. PubMed ID: 6998982
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proceedings: The mechanism of effect of neuropharmacological drugs. I.
    Sklenovský A
    Act Nerv Super (Praha); 1975; 17(4):249-51. PubMed ID: 1221783
    [No Abstract]   [Full Text] [Related]  

  • 59. Free amino acid level determinations in normal and schizophrenic brain.
    Kutay FZ; Pöğün S; Hariri NI; Peker G; Erlaçin S
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):119-26. PubMed ID: 2748856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma creatine phosphokinase in schizophrenia.
    Kondaiah P; Murthy KK; Reddi OS
    Indian J Psychiatry; 1981 Oct; 23(4):351-2. PubMed ID: 22058561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.